Skip to main content
. 2020 Oct 13;8(1):e001715. doi: 10.1136/bmjdrc-2020-001715

Table 2.

Incidence of MetS in group A according to characteristics at baseline

At risk (n) Developing MetS (n) P value OR (95% CI) Person-year Incidence per 1000 person-years (95% CI)
All samples 1146 294 (25.7) 8646 38 (32 to 44)
Gender
 Men 419 153 (36.5) 2.39 (1.82 to 3.13) 3166 48 (41 to 57)
 Women 727 141 (19.4) 0.000 1 5480 26 (22 to 30)
Age (years)
 18–45 592 85 (14.4) 1 4452 19 (15 to 24)
 46–60 361 114 (31.6) 2.75 (2.00 to 3.79) 2730 42 (35 to 50)
 61–75 172 83 (48.3) 5.56 (3.82 to 8.11) 1305 64 (51 to 79)
 ≥76 21 12 (57.1) 0.000 7.95 (3.25 to 19.45) 160 75 (39 to 131)
Marital status
 Single 218 39 (17.9) 1 1650 24 (17 to 32)
 Married/cohabiting 836 235 (28.1) 1.80 (1.23 to 2.62) 6292 37 (33 to 42)
 Widower 43 10 (23.3) 1.39 (0.63 to 3.06) 327 31 (15 to 56)
 Divorced 49 10 (20.4) 0.016 1.18 (0.54 to 2.56) 378 27 (13 to 49)
Educational level
 No studies 62 34 (38.7) 3.70 (1.98 to 6.91) 471 51 (33 to 76)
 Elementary 527 160 (30.4) 2.55 (1.71 to 3.82) 3973 40 (34 to 47)
 Secondary education 316 75 (23.7) 1.82 (1.17 to 2.84) 2380 32 (25 to 40)
 University degree 240 35 (14.8) 0.000 1 1814 19 (13 to 27)
Region of the country
 North 135 26 (19.3) 1 1040 25 (16 to 37)
 South 447 122 (27.3) 1.57 (0.98 to 2.53) 3341 37 (30 to 44)
 Centre 291 85 (29.2) 1.73 (1.05 to 2.84) 2221 38 (31 to 47)
 Northeast 117 26 (22.2) 1.20 (0.65 to 2.21) 916 28 (19 to 42)
 East coast 156 35 (22.4) 0.135 1.21 (0.69 to 2.14) 1127 31 (22 to 43)
Number of components of MetS
 0 294 16 (5.4) 1 2219 7 (4 to 11)
 1 401 72 (18.0) 3.80 (2.16 to 6.69) 3023 24 (19 to 30)
 2 451 206 (45.7) 0.000 14.61 (8.54 to 24.99) 3404 61 (53 to 69)
Glucose regulation
 Normal 885 214 (24.2) 1 6675 32 (28 to 37)
 >99 261 80 (30.7) 0.023 1.39 (1.02 to 1.88) 1971 41 (32 to 51)
HDL-chol low
 No 968 245 (25.3) 1 7303 34 (30 to 38)
 Yes 178 49 (27.5) 0.296 1.21 (0.78 to 1.61) 1343 37 (27 to 48)
Central obesity
 No 750 120 (16.0) 1 5684 21 (18 to 25)
 Yes 396 174 (43.9) 0.000 4.16 (3.12 to 5.44) 2962 59 (50 to 68)
Hypertension
 No 736 141 (19.2) 1 5531 26 (22 to 30)
 Yes 410 153 (37.3) 0.000 2.51 (1.92 to 3.30) 3115 49 (42 to 58)
Hyper-TG
 No 1088 266 (24.4) 1 8206 32 (29 to 37)
 Yes 58 28 (48.3) 0.000 2.89 (1.69 to 4.92) 440 64 (42 to 92)
BMI (kg/m2)
 18–<25 474 45 (9.5) 0.000 1 3582 13 (9 to 17)
 25–<30 488 156 (32.0) 4.48 (3.12 to 6.43) 3683 42 (36 to 50)
 >30 182 91 (50.0) 9.53 (6.25 to 14.55) 1366 67 (54 to 82)
IPAQ
 High 278 69 (24.8) 0.933 1 2103 33 (26 to 42)
 Moderate 387 99 (25.6) 1.04 (0.73 to 1.49) 2921 34 (28 to 41)
 Low 480 125 (26.0) 1.07 (0.76 to 1.50) 3614 35 (29 to 41)
MET-min/week
 >500 777 194 (25.0) 0.241 1 3320 31 (25 to 39)
 ≤500 369 100 (27.1) 1.12 (0.84 to 1.48) 2773 36 (29 to 43)
MEDAS
 <9 345 85 (24.6) 0.330 1 2587 33 (26 to 41)
 >9 801 209 (26.1) 1.08 (0.81 to 1.45) 6059 35 (30 to 40)
 ≤11 1095 282 (25.8) 0.434 1.28 (0.58 to 2.18) 8266 34 (30 to 38)
 >11 51 12 (23.5) 1 379 31 (16 to 55)
Family history of T2DM
 No 528 134 (25.4) 0.425 1 3944 34 (28 to 40)
 Yes 595 155 (26.1) 1.04 (0.79 to 1.35) 4476 35 (29 to 41)

Data are n (%).

BMI, body mass index; HDL-chol, high-density lipoprotein cholesterol; IPAQ, International Physical Activity Questionnaire; MEDAS, Mediterranean Diet adherence screener; MET, metabolic equivalent of task; MetS, metabolic syndrome; T2DM, type 2 diabetes mellitus; TG, triglyceride.